From: Pulmonary salivary gland tumor–hyalinizing clear cell carcinoma: a literature review
Refs | No. of patients | HMB-45 | CK20 | TTF-1 | Napsin A | SMA | S-100 | SOX10 | p40 | p63 | CK7 | CK5/6 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
[1] | 1 | NM | NM | - | - | NM | - | NM | NM | + | + | NM |
[4] | 1 | NM | - | - | - | - | - | NM | + | + | + | NM |
[5] | 3 | 3/3- | NM | 3/3- | 3/3- | NM | NM | 3/3- | 3/3 + | 3/3 + | 3/3 + | 3/3 + |
[6] | 8 | NM | NM | NM | NM | 8/8- | 8/8- | 4/8 + | 5/8 + | 5/8 + | 8/8 + | NM |
[7] | 1 | - | - | - | - | NM | NM | NM | NM | + | - | + |
[12] | 5 | 1/5- | 1/5- | 4/5- | 1/5- | 3/5- | 5/5- | 2/5- | 4/5 + | 3/5 + | 1/5 + | 1/5 + |
[13] | 1 | - | - | - | - | - | - | - | + | + | + | + |
[14] | 1 | NM | NM | - | - | - | - | - | - | - | NM | NM |
[15] | 2 | 2/2- | 2/2- | 2/2- | 2/2- | 2/2- | 2/2/- | NM | NM | 2/2 + | 2/2 + | NM |
[16] | 1 | NM | - | - | - | - | - | NM | + | + | + | + |
[17] | 2 | 2/2- | 2/2- | 2/2- | 2/2- | 2/2- | 2/2- | 2/2- | 2/2 + | 2/2 + | 2/2 + | 2/2 + |
[18] | 1 | NM | NM | NM | NM | NM | - | - | + | + | + | + |
[19] | 1 | NM | NM | NM | NM | - | - | NM | NM | + | NM | NM |
[20] | 1 | NM | NM | NM | NM | NM | NM | NM | NM | NM | NM | NM |
[21] | 2 | 2/2- | NM | 2/2- | NM | NM | 2/2- | NM | NM | 2/2 + | NM | NM |
[22] | 1 | NM | NM | NM | NM | NM | - | - | NM | + | + | NM |
[23] | 1 | NM | NM | NM | NM | - | NM | NM | + | NM | + | + |
[24] | 1 | NM | NM | - | - | - | NM | NM | + | + | + | + |
Total | 34 | (12/16) | (8/12) | (20/21) | (15/19) | (22/24) | (27/27) | (11/22) | (20/24) | (26/31) | (24/28) | (12/16) |
Rate | / | 75%- | 66.7%- | 95.2%- | 78.9%- | 91.7%- | 100%- | 50%- | 83.3%+ | 83.9%+ | 85.7% + | 75% + |